RARE vs STI · rev $350.0M vs rev $210.3K
Ultragenyx (RARE) versus Solidion Technology Inc. (STI) — a side-by-side from cached financials, not a winner call.
Ultragenyx (RARE) is a biotechnology company listed on US.
Solidion Technology Inc. (STI) is a electrical equipment & parts company listed on US.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
Latest reported STI revenue for 2026-06-30 was $210.3K. Net income was -$4.3M. STI currently screens at market cap $276.7M.
RARE currently screens at market cap $2.79B. STI currently screens at market cap $276.7M.
Not investment advice. Open the RARE and STI stock pages for the full models.
Not investment advice.